Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneWEAVE
Los Gatos, California, United States
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
GeneWEAVE developed Smarticles technology for rapid identification of multidrug-resistant organisms (MDROs) and antibiotic susceptibility directly from clinical samples. In trials, Smarticles technology reduced time to therapy, hospital stays, and mortality, and was not yet FDA approved at acquisition. The vivoDx system was in late-stage development with positive pilot results, but not commercially launched before acquisition.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceMolecular diagnostics
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on GeneWEAVE.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeneWEAVE.